- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
iCAD third quarter revenues drop
Third quarter revenues at computer-aided detection specialist iCAD dropped 37% to $7.1 million, but the company stayed in the black with net income of $113,000 compared with net income of $2.1 million in the year earlier period.
iCAD third quarter revenues drop
Third quarter revenues at computer-aided detection specialist iCAD dropped 37% to $7.1 million, but the company stayed in the black with net income of $113,000 compared with net income of $2.1 million in the year earlier period. For the first nine months total revenue declined 29% to $20.0 million from $28.2 million. Sales of digital CAD and MRI products led the decline with revenues falling to $12.7 million compared with $20.4 million over the two nine-month periods. Service and supply revenues actually increased to $2.8 million compared with $2.5 million. Film-based revenue of $4.6 million fell from $5.3 million. The company’s core digital mammography CAD business showed increased demand in the third quarter versus the second quarter, according to the company, as evidenced by the increased placements of full-field digital mammography systems posted in the Mammography Quality Standards Act data on the FDA website. Overall, revenues grew 24% compared with the second quarter of 2009. Ken Ferry, iCAD president and CEO, said he expects the sequential revenue growth to continue into the fourth quarter.
Computed Tomography Study Assesses Model for Predicting Recurrence of Non-Small Cell Lung Cancer
January 31st 2025A predictive model for non-small cell lung cancer (NSCLC) recurrence, based on clinical parameters and CT findings, demonstrated an 85.2 percent AUC and 83.3 percent sensitivity rate, according to external validation testing in a new study.
